The shares of the electrical control panels manufacturing hit 10 percent upper circuit after the company received a letter of business award (LoBA) from Mahindra & Mahindra Limited worth Rs 450 crore.
With a market capitalization of Rs 388.52 crore, the shares of Saakshi Medtech & Panels Ltd were trading at Rs 220.05 per share, increasing around 10 percent as compared to the previous closing price of Rs 200.05 apiece.
Reason for the rise:-
Today, the shares of the company have seen positive movement after Saakshi Medtech & Panels Ltd received a Letter of Business Award (LoBA) from Mahindra & Mahindra Limited for “Supply of EV Panels” including 3 (Three) years Guarantee/ Warranty. The total order value is around Rs. 250 crore for 5 years (till 2029).
Financial performance:-
Analyzing the company’s financial condition, revenue ramped down by 28 percent from Rs 61 crore in H1FY24 to Rs 44 crore in H1FY25, during the same time frame net profit plummeted by 50 percent from Rs 6 crore to Rs 3 crore.
Ratio analysis:-
The company’s critical ratios show that the return on equity decreased from 29.30 percent in FY22-23 to 12.11 percent in FY23-24, while the return on capital employed increased from 34.49 percent to 15.06 percent. The net profit margin (NPM) for fiscal year 23-24 is 9.27 percent.
Shareholding pattern:-
In the company’s recent shareholding pattern, the Promoters of the company own 73.63 percent while Retail shareholders own a 24.73 percent stake in the company and Foreign Institutional Investors own a 0.11 percent stake.
Company snapshot:-
Saakshi Medtech and Panels Ltd are engaged in the manufacturing of electrical control panels and cabinets. The Company’s manufactured electrical control panels and cabinets are used in elevators, air compressors, the renewable energy industry, the oil and gas exploration industry, and electrical vehicle charging stations.
Written by:- Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
